BioRestorative Therapies Inc Watch

from 8-K 8 pages Amended and Restated Dip Loan and Security Agreement by and Between BioRestorative Therapies, Inc., as Borrower and Phoenix Cell Group Holdings, LLC, as Lender Dated: March 30, 2020

from 8-K 46 pages Dip Loan and Security Agreement by and Between Biorestoratice Therapies, Inc., as Borrower and Phoenix Cell Group Holdings, LLC, as Lender Dated: March 19, 2020

from 10-K 2 pages December 14, 2016 Reference Is Made to the Promissory Note of Even Date From BioRestorative Therapies, Inc. (The “Company”) to You With Respect to a Loan Made by You to the Company in the Amount of $60,000. in Consideration of Your Loan, the Company Agrees That the Expiration Dates of the Warrants, Dated March 18, 2016, Issued to You for the Purchase of 444,444 and 400,000 Shares of the Company’s Common Stock, Respectively (The “Warrants”), Are Extended to December 31, 2018. Except as Modified Herein, the Warrants Shall Continue in Full Force and Effect in Accordance With Their Terms. Very Truly Yours, BioRestorative Therapies, Inc. By: Mark Weinreb, Chief Executive Officer

from 10-K 2 pages Reference Is Made to the Subscription Agreements, Dated February 10, 2011, November 4, 2011, March 30, 2012 and March 26, 2013 (The “Agreements”), by and Among Stem Cell Cayman Ltd. (“Cayman”), BioRestorative Therapies, Inc. (Formerly Stem Cell Assurance, Inc.) (“Biorestorative”) and Westbury (Bermuda) Ltd. (The “Lender”) With Respect to Loans Made by the Lender to Cayman in the Amounts of $1,050,000, $1,000,000, $1,500,000 and $450,000, Respectively (The “Principal Amounts”), Evidenced by Promissory Notes, Dated February 10, 2011, November 4, 2011, March 30, 2012 and March 27, 2013, as Amended, in the Respective Principal Amounts (The “Notes”), Which Provide, as Amended, That the Respective Principal Amounts Are Payable on December 31, 2014 (The “Maturity Date”). the Lender Agrees That Cayman and BioRestorative Have Performed All of Their Obligations Under the Agreements and the Notes, and the Lender Waives Any and All Defaults by Cayman and BioRestorative Thereunder. the Parties Agree That the Notes Are Hereby Amended Such That the Maturity Date for the Payment of the Respective Principal Amounts Shall Be June 30, 2015. No Interest Shall Be Payable on the Notes

from 10-K 2 pages Reference Is Made to the Subscription Agreements, Dated February 10, 2011, November 4, 2011 and March 30, 2012 (The “Agreements”), by and Among Stem Cell Cayman Ltd. (“Cayman”), BioRestorative Therapies, Inc. (Formerly Stem Cell Assurance, Inc.) (“Biorestorative”) and Westbury (Bermuda) Ltd. (The “Lender”) With Respect to Loans Made by the Lender to Cayman in the Amounts of $1,050,000, $1,000,000 and $1,500,000, Respectively (The “Principal Amounts”), Evidenced by Promissory Notes, Dated February 10, 2011, November 4, 2011 and March 30, 2012 in the Respective Principal Amounts (The “Notes”), Which Provide, as Amended, That the Respective Principal Amounts Are Payable on March 30, 2013 (The “Maturity Date”)

from 10-12G 11 pages Credit Support, Security and Registration Rights Agreement